IRIS
EVANGELISTA, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 7.310
NA - Nord America 5.556
SA - Sud America 1.476
EU - Europa 917
AF - Africa 146
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 4
Totale 15.430
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.377
SG - Singapore 5.142
BR - Brasile 1.218
CN - Cina 840
VN - Vietnam 662
DE - Germania 350
HK - Hong Kong 132
IT - Italia 120
IN - India 111
AR - Argentina 89
BD - Bangladesh 79
GB - Regno Unito 77
CA - Canada 72
MX - Messico 64
IQ - Iraq 51
RU - Federazione Russa 51
EC - Ecuador 50
ZA - Sudafrica 41
PL - Polonia 39
TR - Turchia 38
FR - Francia 35
NL - Olanda 34
CO - Colombia 29
ES - Italia 29
VE - Venezuela 29
MA - Marocco 26
UA - Ucraina 24
SA - Arabia Saudita 23
ID - Indonesia 22
AT - Austria 21
PK - Pakistan 21
PH - Filippine 19
AE - Emirati Arabi Uniti 18
CL - Cile 18
IE - Irlanda 18
JP - Giappone 18
SE - Svezia 18
FI - Finlandia 17
CZ - Repubblica Ceca 16
KE - Kenya 15
AU - Australia 14
AZ - Azerbaigian 13
IL - Israele 13
PE - Perù 13
TN - Tunisia 13
UZ - Uzbekistan 13
AL - Albania 12
NG - Nigeria 11
PY - Paraguay 11
BO - Bolivia 10
DZ - Algeria 10
EG - Egitto 10
LT - Lituania 9
MY - Malesia 9
JO - Giordania 8
NP - Nepal 8
OM - Oman 8
KG - Kirghizistan 7
KW - Kuwait 7
UY - Uruguay 7
HN - Honduras 6
LV - Lettonia 6
TW - Taiwan 6
DO - Repubblica Dominicana 5
GR - Grecia 5
GT - Guatemala 5
IR - Iran 5
JM - Giamaica 5
KZ - Kazakistan 5
SY - Repubblica araba siriana 5
TT - Trinidad e Tobago 5
CR - Costa Rica 4
DK - Danimarca 4
ET - Etiopia 4
GA - Gabon 4
GE - Georgia 4
NI - Nicaragua 4
PT - Portogallo 4
SN - Senegal 4
BA - Bosnia-Erzegovina 3
BE - Belgio 3
BH - Bahrain 3
BW - Botswana 3
BY - Bielorussia 3
LB - Libano 3
NO - Norvegia 3
NR - Nauru 3
PS - Palestinian Territory 3
RO - Romania 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BB - Barbados 2
BG - Bulgaria 2
DM - Dominica 2
GY - Guiana 2
HR - Croazia 2
KH - Cambogia 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
Totale 15.403
Salva come PNG Salva come JPEG
Città #
Singapore 2.175
Ashburn 1.112
San Jose 1.112
Dallas 877
The Dalles 848
Shanghai 422
Ho Chi Minh City 226
Falkenstein 224
Beijing 176
Hanoi 144
Hong Kong 121
São Paulo 115
Los Angeles 92
Seattle 71
New York 64
Santa Clara 55
Council Bluffs 43
Boardman 42
Da Nang 37
Warsaw 33
Brooklyn 31
Assago 30
Chennai 30
Chandler 29
Haiphong 29
Munich 29
Rio de Janeiro 29
Montreal 27
Orem 27
Curitiba 26
Boston 23
Brasília 23
Wilmington 23
Belo Horizonte 21
Guayaquil 21
Baghdad 20
Chicago 20
Dhaka 20
Milan 19
Toronto 19
Goiânia 18
Johannesburg 18
Campinas 17
Dublin 17
Stockholm 17
Helsinki 16
Quito 16
Tokyo 15
Amsterdam 14
Atlanta 14
Buenos Aires 14
Phoenix 14
San Mateo 14
Ann Arbor 13
Biên Hòa 13
Charlotte 13
London 13
Mexico City 13
Baku 12
Frankfurt am Main 12
Guarulhos 12
Porto Alegre 12
Salvador 12
San Francisco 12
Bắc Ninh 11
Nairobi 11
New Delhi 11
Ribeirão Preto 11
Brno 10
Cape Town 10
Düsseldorf 10
Fortaleza 10
Istanbul 10
Reston 10
Santo André 10
Tashkent 10
Vienna 10
Ankara 9
Bắc Giang 9
Caxias do Sul 9
Dubai 9
Jeddah 9
Riyadh 9
Blumenau 8
Denver 8
Hải Dương 8
Lima 8
Manila 8
Montes Claros 8
Nuremberg 8
Santiago 8
Sumaré 8
Thái Nguyên 8
Agadir 7
Amman 7
Bishkek 7
Buffalo 7
Bến Tre 7
Delhi 7
Hillsboro 7
Totale 9.143
Salva come PNG Salva come JPEG
Nome #
10-Year Clinical Experience with 18F-Choline PET/CT: An Italian Multicenter Retrospective Assessment of 3343 Patients 621
PET-CT radiomics for immunotherapy response 142
18F-fluorodeoxyglucose PET/computed tomography and risk stratification after neoadjuvant treatment in esophageal cancer patients 112
A prospective trial for the evaluation of esophageal cancer patients: FDG PET/CT vs. c.e.CT vs. FDG PET/c.e.CT 92
BNCT treatment: 18F-FBPA PET-CT 92
Detection rate of 18F-Choline positron emission tomography/computed tomography in patients with non-metastatic hormone sensitive and castrate resistant prostate cancer 78
18F-FET PET/CT in Calcifying Pseudoneoplasm of the Neuraxis: First Case 76
An incidental pancreatic finding at 18F-choline PET/CT: Chronic mass-forming pancreatitis 75
SEGMENTAL FDG-PET/CT IN SOLITARY PULMONARY NODULE: PRELIMINARY DATA OF THE PET ITALIAN TRIAL 75
Advantages of SiPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review—Part 1 oncological setting 70
Development and evaluation of a bayesian optimization FDG population-based input function for implementing parametric imaging in the clinical practice 66
Emerging Radiopharmaceuticals in Pet Imaging for Mesothelioma: A Review of [18F]FDG Alternatives 65
Non-palpable Pulmonary Nodules and Uniportal-VATS: Radio-guided Localization (ROLL) Experience of a Lung Multidisciplinary Team 62
18F-FDG PET/CT and urothelial carcinoma: Impact on management and prognosis—a multicenter retrospective study 61
New target therapies in prostate cancer: from radioligand therapy, to PARP-inhibitors and immunotherapy 60
18F-DOPA and 18F-FDG PET/CT, scintigraphic localization and radioguided surgery of recurrent medullary thyroid cancer: two case reports 60
Comparison between conventional imaging (CI) and wholebody 18F-choline (FCH) positron emission tomography/ computed tomography (PET/CT) in patients (pts) with prostate cancer (PCa) 59
Advancing Prostate Cancer Care: Prostate-specific Membrane Antigen–based Radioligand Therapy at the Forefront 57
18F-Fluoroestradiol Positron Emission Tomography In Breast Cancer Patients: Systematic Review Of The Literature &; Meta-Analysis 57
18F-FDG PET-Derived Volume-Based Parameters to Predict Disease-Free Survival in Patients with Grade III Breast Cancer of Different Molecular Subtypes Candidates to Neoadjuvant Chemotherapy 56
Positron emission tomography/computed tomography and esophageal cancer in the clinical practice: How does it affect the prognosis? 54
MUNES: a MUltidisciplinar Neutron Source for BNCT and Nuclear Waste characterization 54
18F-Choline PET/CT: An Alternative Tracer for Hodgkin Lymphoma? 53
18F-choline PET/CT in prostate cancer for the staging, the restaging and planning radiotherapy treatment 53
Diagnosi e stadiazione del cancro della mammella Il Medico Nucleare: stato dell’arte e risposta ai punti controversi 52
18F-Choline PET/CT and prostatic gland/fossae recurrence: what can help to identify the local recurrence of disease? 52
18F-Choline: Prostate Cancer18F-choline PET/CT: an increasing role in cancer evaluation 52
An Evaluation of the Diagnostic Accuracy of [68Ga]Ga-PSMA-11 vs. [18F]F-PSMA-1007 PET/CT for Lymph Node Staging in Patient Candidates for Radical Prostatectomy and Lymph Node Dissection: A Single Institutional Analysis 51
18F-FDG or 68Ga/18F-PSMA PET/CT in recurrent renal cancer? 51
Radiomics and theranostics with molecular and metabolic probes in prostate cancer: toward a personalized approach 51
[18F]FDG and Lymphomas: Still a Winning Golden Couple in the Era of FAPI-Based Radiotracers 50
18F-choline PET/CT and PET/MRI in primary and recurrent hyperparathyroidism: a systematic review of the literature 50
Relazione tra ischemia miocardica inducibile e livelli plasmatici di proteina C reattiva in pazienti con sospetta cardiopatia ischemica 50
18F-DOPA PET/CT in different neuroendocrine settings: staging, restaging and increase in tumor markers 50
L’imaging funzionale nelle disautonomie 49
PET Radiomics and Response to Immunotherapy in Lung Cancer: A Systematic Review of the Literature 49
18F-FDG PET/CT in gynecologic malignancies: single Institution experience 49
Diagnostic and prognostic value of gated myocardial perfusion single-photon emission computed tomography in low-risk patients with left bundle-branch block 49
Advantages of SiPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review– part 2 48
18 F-Choline PET/CT in Leptomeningeal Breast Cancer Metastases 48
The role of 18f-fdg pet/ct in staging and prognostication of mantle cell lymphoma: An italian multicentric study 48
18F-FDG PET/MRI in adult sarcomas 48
State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation 48
PET/MR in recurrent glioblastoma patients treated with regorafenib: [18F]FET and DWI-ADC for response assessment and survival prediction 47
Prostate MRI and PSMA-PET in the Primary Diagnosis of Prostate Cancer 47
18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapy 46
Clinical Application of PET/MRI 46
Diagnostic and prognostic impact of fluorine-18-fluorodeoxyglucose PET/CT in preoperative and postoperative setting of breast cancer patients 46
Ruolo della Tomografia ad emissione di fotone singolo nella definizione della probabilità di cardiopatia ischemica nei pazienti diabetici: risultati di un trial multi prospettico, multicentrico 45
The ability of 18F-choline PET/CT to identify local recurrence of prostate cancer 45
Staging of locally advanced breast cancer and the prediction of response to neoadjuvant chemotherapy: complementary role of scintimammography and 18F-FDG PET/CT 45
Role of molecular imaging in the management of patients affected by inflammatory bowel disease: State-of-the-art 44
Usefullness of stress cardiac single photon emission computesd tomography iomaging late after percutaneous coronary intervention for assessing cardiac events and time to such events 44
Incidental Detection of Sarcomatoid Lung Cancer by [18F] Choline Positron Emission Tomography/Computed Tomography 44
PET-guided prognosis: a promising role of metabolic imaging in esophageal cancer. 44
Gleason score at diagnosis predicts the rate of detection of 18F-choline PET/CT performed when biochemical evidence indicates recurrence of prostate cancer: experience with 1,000 patients 44
Head-to-head comparison between 18F-FDG PET/CT and PET/MRI in breast cancer 44
The evolution of PET imaging in renal, bladder, upper urinary tract urothelial, testicular and penile carcinoma – Today’s impact, tomorrow’s potential 44
18F-Fluoroestradiol positron emission tomography in breast cancer patients: systematic review of the literature & meta-analysis 44
18F-FDG PET/CT in ovarian cancer 44
ENDOCRINE ORGANS INVOLVEMENT IN BREAST CANCER: WHEN THE TEAMWORK MAKES THE DIFFERENCE 44
The performance of FDG PET/CT in single pulmonary nodules (SPNs): preliminary analysis from The Italian Tailored Assessment of Lung Indeterminate Accidental Nodule (ITALIAN) multicentre trial 43
Somatostatin Receptor PET/CT Imaging for the Detection and Staging of Pancreatic NET: A Systematic Review and Meta-Analysis 43
An Incidental Uptake of 18F-Choline at PET/CT in Gastric Neuroendocrine Tumor 43
Il radiologo e il medico nucleare: nodulo/i polmonare/i 42
Diagnostic value of contrast-enhanced CT combined with 18-FDG PET in patients selected for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) 42
Tumour marker guided Positron Emission Tomography in Breast Cancer patients: A recipe for a perfect wedding. A systematic literature review & meta-analysis 42
Lymphoid organs’ metabolism and its role in predicting the outcomes of patients with malignant melanoma treated with immunotherapy: an exploratory study 42
Therapeutic impact of (18)F-FDG PET/CT in recurrent differentiated thyroid carcinoma 41
Copper, PeT/cT and prostate cancer: A systematic review of the literature 41
Head-to-Head Comparison between Peptide-Based Radiopharmaceutical for PET and SPECT in the Evaluation of Neuroendocrine Tumors: A Systematic Review 41
Clinical Impact of 18F-FDG PET/CT in the Diagnostic Workup of Pancreatic Ductal Adenocarcinoma: A Systematic Review 41
A false-positive finding in 18F-FDG PET/CT images in patients with right Malignant Pleural Mesothelioma (MPM) after extrapleural pneumonectomy 41
Prevalence of interstitial pneumonia suggestive of COVID-19 at 18F-FDG PET/CT in oncological asymptomatic patients in a high prevalence country during pandemic period: a national multi-centric retrospective study 41
Will68Ga PSMA-radioligands be the only choice for nuclear medicine in prostate cancer in the near future? A clinical update 41
Cardiac performance during exercise in hypertensive patients without ventricular hypertrophy 40
Boron neutron capture therapy and 18F-labelled borophenylalanine positron emission tomography: a critical and clinical overview of the literature 40
The role of fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) versus diagnostic CT in surgical management of patients (pts) with lung cancer according to the 7th TNM classification 40
PET/CT And The Response To Immunotherapy In Lung Cancer 40
Additional Value of PET and CT Image-Based Features in the Detection of Occult Lymph Node Metastases in Lung Cancer: A Systematic Review of the Literature 40
EARLY AND LATE IMAGES OF 18F-CHOLINE (FCH) PET/CT FOR THE DETECTION OF PROSTATIC FOSSAE RECURRENCES IN PROSTATE CANCER WITH A BIOCHEMICAL FAILURE (PSA< 2 NG/ML) 40
The Future Direction of Women in Nuclear Medicine and Nuclear Medicine in Women's Health 40
Role of SPECT imaging in the definition of cardiac risk in daibetic patients without history of coronary artery disease: results of a prospective, multi-center trials 40
Role of FDG-PET/CT in the staging of colonrectal cancer 40
Risk stratification and prognostic assessment by myocardial perfusion-gated SPECT in patients with left bundle-branch block and low-intermediate cardiac risk 40
Accuracy of 18F-FDG PET/CT versus bone marrow biopsy in assessing bone marrow involvement in paediatric Hodgkin's Lymphoma. Accuracy in a multicenter series of 156 patients 40
Interpretative reproducibility of cardiac stress imaging: direct comparison between dobutamine echocardiography and single photon emission computed tomography 40
Boron Neutron Capture Therapy 40
What are the best ways to reduce the false-positive rate of 18F-FDG PET/CT in patients with breast cancer? 39
Effects of the High Definition technology on Standardized Uptake Values (SUVs) obtained by Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET)/Computed Tomography (CT) 39
Molecular imaging: the emerging role of optical imaging in nuclear medicine 39
Pharmacovigilance and radiopharmaceutical: adverse events in prostate cancer diagnosis and treatment 39
Ruolo della PET/scintigrafia ossea? 39
Comparison between18F-Dopa and 18F-Fet PET/CT in patients with suspicious recurrent high grade glioma: A literature review and our experience 39
Relation between wall thickening on gated perfusion SPECT and functional recovery after coronary revascularization in patients with previous myocardial infarction 39
Ruolo della PET nella malattia oligometastatica 39
Ga-68 DOTA-peptides and F-18 FDG PET/CT in patients with neuroendocrine tumor: A review 39
THE EFECTS OF 18F-FDG PET/CT ON THE MANAGEMENT AND PROGNOSIS OF PATIENTS WITH BLADDER CANCER (Bca) AND UPPER URINARY TRACT UROTHELIAL CARCINOMA (UTUC) 39
Molecular imaging of PARP in cancer: state-of-the-art 39
An incidental finding behind adrenal incidentaloma 39
Totale 5.574
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.959
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.959
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112 0 0 0 0 0 0 0 0 0 6 0 6
2021/202229 1 0 1 8 1 2 1 1 4 2 6 2
2022/202375 12 5 8 12 3 5 0 3 14 5 8 0
2023/20241.128 2 5 9 4 1 10 3 4 377 59 282 372
2024/20254.366 119 153 19 77 50 505 226 206 878 1.137 480 516
2025/202610.205 1.633 682 874 848 419 632 3.517 680 475 445 0 0
Totale 15.858